P Wilding

668 total citations
10 papers, 541 citations indexed

About

P Wilding is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Animal Science and Zoology. According to data from OpenAlex, P Wilding has authored 10 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Animal Science and Zoology. Recurrent topics in P Wilding's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (4 papers) and Pharmacological Effects and Assays (3 papers). P Wilding is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (4 papers) and Pharmacological Effects and Assays (3 papers). P Wilding collaborates with scholars based in United Kingdom. P Wilding's co-authors include Amanda Wheatley, Stephen B. Liggett, Ian P. Hall, Ian Pavord, Elizabeth Clark, AE Tattersfield, Janet Oborne, Anne E. Tattersfield, Sarah Lewis and Lesley Rushton and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

P Wilding

10 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Wilding United Kingdom 8 414 281 94 88 44 10 541
Rajesh Bhagat United States 15 457 1.1× 404 1.4× 81 0.9× 53 0.6× 60 1.4× 27 688
A.S. Vathenen United Kingdom 9 561 1.4× 535 1.9× 38 0.4× 86 1.0× 53 1.2× 10 734
W. Kepron Canada 15 367 0.9× 268 1.0× 106 1.1× 33 0.4× 182 4.1× 26 660
Earle B. Weiss United States 11 229 0.6× 192 0.7× 60 0.6× 14 0.2× 52 1.2× 22 418
R. F. M. Gomes Canada 6 191 0.5× 287 1.0× 35 0.4× 15 0.2× 32 0.7× 6 435
Michele Baroffio Italy 12 158 0.4× 186 0.7× 41 0.4× 22 0.3× 36 0.8× 21 333
B. Marchette United States 12 216 0.5× 141 0.5× 27 0.3× 15 0.2× 64 1.5× 20 343
G Kessler Germany 6 256 0.6× 199 0.7× 37 0.4× 24 0.3× 67 1.5× 13 358
Jeng‐Dau Tsai Taiwan 13 126 0.3× 54 0.2× 62 0.7× 16 0.2× 53 1.2× 43 475
Nicki M. Nair United States 8 640 1.5× 474 1.7× 52 0.6× 7 0.1× 192 4.4× 12 825

Countries citing papers authored by P Wilding

Since Specialization
Citations

This map shows the geographic impact of P Wilding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Wilding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Wilding more than expected).

Fields of papers citing papers by P Wilding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Wilding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Wilding. The network helps show where P Wilding may publish in the future.

Co-authorship network of co-authors of P Wilding

This figure shows the co-authorship network connecting the top 25 collaborators of P Wilding. A scholar is included among the top collaborators of P Wilding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Wilding. P Wilding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Harrison, Tim, Janet Oborne, P Wilding, & AE Tattersfield. (1999). Randomised placebo controlled trial of beta  agonist dose reduction in asthma. Thorax. 54(2). 98–102. 5 indexed citations
2.
Coon, Jo Thompson, et al.. (1998). The airway effects of stopping regular oral theophylline in patients with asthma. British Journal of Clinical Pharmacology. 45(4). 402–404. 8 indexed citations
3.
Wilding, P, Elizabeth Clark, Sarah Lewis, et al.. (1997). Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ. 314(7092). 1441–1441. 106 indexed citations
4.
Egbagbe, Eruke E, Ian Pavord, P Wilding, Jo Thompson Coon, & AE Tattersfield. (1997). Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax. 52(3). 239–243. 48 indexed citations
5.
Pavord, Ian, et al.. (1996). The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. European Respiratory Journal. 9(2). 217–219. 32 indexed citations
6.
Wilding, P, et al.. (1996). Effect of regular terbutaline on the airway response to inhaled budesonide.. Thorax. 51(10). 989–992. 14 indexed citations
7.
Pye, Stephen R., et al.. (1995). A Comparison of the Effects of Inhaled Furosemide and Ethacrynic Acid on Sodium-Metabisulfite-Induced Bronchoconstriction in Subjects with Asthma. American Journal of Respiratory and Critical Care Medicine. 151(2). 337–339. 5 indexed citations
8.
Hall, Ian P., Amanda Wheatley, P Wilding, & Stephen B. Liggett. (1995). Association of Glu 27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. The Lancet. 345(8959). 1213–1214. 245 indexed citations
9.
Shakib, Farouk, et al.. (1994). Circulating levels of IgG1 and IgG4 Anti‐IgE antibodies and asthma severity. Allergy. 49(3). 192–195. 14 indexed citations
10.
Pavord, Ian, et al.. (1994). Systemic effects of salbutamol and salmeterol in patients with asthma.. Thorax. 49(8). 771–774. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026